View in EDS HTML Full Text PDF Full Text

One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Saved in:
Bibliographic Details
Title: One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.
Authors: Kitay, Alice M.1 (AUTHOR), Tillmann, Anne2 (AUTHOR), Pfister, Isabel3 (AUTHOR), Schild, Christin3 (AUTHOR), Bonanata, Matteo4 (AUTHOR), Heck, Katharina5 (AUTHOR), Spitznagel, Tahm6,7 (AUTHOR), Gabathuler, Felix8 (AUTHOR), Bartolomeo, Nicolo9 (AUTHOR), Magnin, Simon10 (AUTHOR), Löliger, Jordan11 (AUTHOR), Munk, Marion R.2,12,13 (AUTHOR), Menghini, Moreno4 (AUTHOR), Hatz, Katja5 (AUTHOR), Somfai, Gábor Márk6,7,14 (AUTHOR), Zweifel, Sandrine8 (AUTHOR), Ambresin, Aude9 (AUTHOR), Eandi, Chiara M.10,15 (AUTHOR), Feltgen, Nicolas11 (AUTHOR), Weinberger, Andreas16 (AUTHOR)
Source: Ophthalmology & Therapy. Apr2026, Vol. 15 Issue 4, p1375-1388. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938245
DOI:10.1007/s40123-026-01344-x